Home Reimbursed medicines Mirdametinib

Mirdametinib — maximum prices and reimbursement

The CANAMED catalogue contains 10 medicines with the active substance Mirdametinib, from 1 manufacturer. Below you can see each entry with the brand name, the manufacturer, the maximum retail price and the prescription status — plus live pharmacy prices, where we track them.

10 CANAMED entries
1 Manufacturers
29569.55–118060.74 Maximum price (RON)
Search live prices → All reimbursed medicines →

In short: for the active substance Mirdametinib there are 10 authorised medicines in the CANAMED catalogue, with maximum retail prices between 29569.55 and 118060.74 RON, from 1 manufacturer. The reimbursement percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price, not to the shelf price. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.

Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.

CANAMED catalogue

All medicines with Mirdametinib

Maximum retail price = the legal selling cap. Sorted by price, lowest first.

Brand name Manufacturer Maximum price Reimbursement Prescription
EZMEKLY 1 mg MIAS PHARMA LIMITED - IRLANDA 29569.55 RON not reimbursed PR
EZMEKLY 1 mg MIAS PHARMA LIMITED - IRLANDA 29569.55 RON not reimbursed PR
EZMEKLY 1 mg MIAS PHARMA LIMITED - IRLANDA 29569.55 RON not reimbursed PR
EZMEKLY 1 mg MIAS PHARMA LIMITED - IRLANDA 29569.55 RON not reimbursed PR
EZMEKLY 1 mg MIAS PHARMA LIMITED - IRLANDA 59066.61 RON not reimbursed PR
EZMEKLY 1 mg MIAS PHARMA LIMITED - IRLANDA 59066.61 RON not reimbursed PR
EZMEKLY 2 mg MIAS PHARMA LIMITED - IRLANDA 59066.61 RON not reimbursed PR
EZMEKLY 2 mg MIAS PHARMA LIMITED - IRLANDA 59066.61 RON not reimbursed PR
EZMEKLY 2 mg MIAS PHARMA LIMITED - IRLANDA 118060.74 RON not reimbursed PR
EZMEKLY 2 mg MIAS PHARMA LIMITED - IRLANDA 118060.74 RON not reimbursed PR

Prescription status key:

  • PR — With a medical prescription (PR)

This catalogue does not record the reimbursement percentage per product. Reimbursement is set through the CNAS sublists — A 90%, B 50%, C1/C2 100%, D 20% of the reference price — see the full explanation of the sublists or ask the pharmacist for the exact placement.

Live pharmacy prices

Products with Mirdametinib in our comparator

Shelf prices collected from the large chains — see on each product page where it is cheapest.

Good to know

How to read the maximum price

The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.

CANAMED catalogue

Other active substances in the catalogue

See also the full list of reimbursed medicines, with an alphabetical index of all active substances.

Frequently asked questions

FAQ · Mirdametinib

  1. Is Mirdametinib reimbursed?
    Reimbursement for Mirdametinib depends on the CNAS sublist the prescribed product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and on the reference price of the therapeutic group — not on the shelf price. The electronic prescription automatically shows the sublist and your contribution; ask the doctor or pharmacist for your exact situation.
  2. What is the CANAMED maximum price for Mirdametinib?
    The maximum retail prices (the CANAMED legal cap) for medicines with Mirdametinib are between 29569.55 and 118060.74 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator.
  3. What percentage of Mirdametinib is reimbursed?
    The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription.
  4. How many medicines with Mirdametinib are in the CANAMED catalogue?
    The CANAMED catalogue holds 10 authorised medicines with the active substance Mirdametinib — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.

Before you go

Find the best price for Mirdametinib

Compare prices →